Healthscope rejects competing takeover approaches

By Thierry Boudan

Australian healthcare company Healthscope has rejected both the AUD$4.35bn (USD$3.3bn) and AUD$4.1bn (USD$3.1bn) competing takeover offers from Brookfield Asset Management and BGH Capital, stating that both proposals undervalue the company.

“The Directors have carefully considered each proposal and concluded that neither proposal adequately reflects the long-term value of Healthscope, nor its underlying assets nor future potential,” said Healthscope Chairman Paula Dwyer.

See also:

The rejection of both bids is being described as a risk by analysts, with the thought being that Healthscope made the decision in the hope of getting a more generous offer.

The move comes despite Healthscope lowering its full-year earnings estimates from approximately $359mn to between $340-345mn as Australians have continued to opt more readily for public health services.

Off the back of the announcement, Healthscope shares slipped as much as 7% in trading.

Further, the company stated that it has put its Asian pathology business up for sale having received significant interest in the division from a number of different parties.

Share

Featured Articles

The world’s biggest chipmaker bets big on renewable energy

Despite the struggle faced by chipmakers to reduce emissions, Taiwan Semiconductor Manufacturing is accelerating renewable energy adoption by 10 years

Uniqlo shakes up leadership amid global retail ambitions

Fast Retailing, the group behind Japan’s Uniqlo, overtakes Gap with soaring profits and is now eyeing accelerated global expansion with executive shakeup

What is the ESG strategy of Chinese automaker Geely Holding?

Chinese automotive giant Geely Holding released its 2022 sustainability report, so what is the car maker’s ESG strategy?

Top 10 best-performing CEOs in Singapore

Leadership & Strategy

Top 10 women behind India’s most successful tech startups

Leadership & Strategy

Top 10 best private members clubs in Singapore and Hong Kong

Leadership & Strategy